MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Looks to AI to Improve Clinical Decision Making for Ovarian Cancer Patients

 Predictive Oncology (NASDAQ: POAI), through its wholly owned subsidiary, Helomics, has sought to end the alarming statistics surrounding ovarian cancer. According to figures provided by the American Cancer Society and quoted by an article discussing POAI’s motivations and operations, “an estimated 21,750 women received a new diagnosis of ovarian cancer this year (2020), and almost 14,000 women will die from the disease. Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women.” In a bid to change this reality, Predictive Oncology, a company that focuses on using data and artificial intelligence to develop personalized cancer therapies, has partnered with the University of Pittsburg School of Medicine, through Helomics, “to study the use of artificial intelligence (‘AI’) to improve clinical decision making for ovarian cancer patients. The collaboration entails using Helomics’ AI platform and proprietary data to analyze the genomic and drug response profiles of women with ovarian cancer to evaluate predictive values in terms of response and non-response to different treatments… Helomics’ predictive models will save time and money in the search for new targeted therapies.”

To view the full article, visit https://ibn.fm/XFUqG

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins, including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Releases Record-Breaking Gross Revenue for January 2021

 

• Company reports record gross revenues of C$1,089,502 last month
• “It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” states CEO
• Record revenue comes during one of slowest e-commerce periods of year, highlighting impact the company has in the plant-based marketplace

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) saw record gross revenues last month (https://ibn.fm/qro4v). The company released its monthly numbers, noting that gross revenues for January 2021 totaled a record-breaking C$1,089,502; cost of goods sold for the month reached C$751,356.

“It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” said PlantX CEO Julia Frank. “There are many other colorful growth opportunities on the horizon, and we’re confident that our financial trajectory will reflect the remarkable and increasing value our company brings to the plant-based industry.”

PlantX Life stated that its January numbers surpassed its December 2020 gross revenues of $1,029,883, which were achieved during a highly dynamic holiday season. “This was surpassed by January 2021’s revenue, which exceeded management’s expectations given that e-commerce sales were expected to be slower following the holiday season,” the announcement noted. “This success during one of the slowest e-commerce periods of the year highlights the tremendous impact the company continues to have in the plant-based marketplace.” The announcement stated that the company’s growth reflects its commitment to meet consumer demand and continues to be driven by its innovative partnerships as well as its marketing and branding efforts.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, PlantX currently has plans to expand its product lines to include cosmetics, clothing and its own water brand.

In addition, the company uses its digital platform to build a community of like-minded consumers and to provide education. Its successful enterprise is being built and fortified through partnerships with top nutritionists, chefs and brands. For example, the company offers 20 unique pre-made meals designed by top chefs and nutritionists. These healthy meals are offered at extremely competitive prices with fast shipping and round-the-clock convenience.

The company’s commitment to customer service is the driving force behind its e-commerce platform, with innovative thinking driving its operation; the PlantX team is constantly envisioning new ways to collaborate with local restaurateurs and entrepreneurs to bring PlantX to the world. PlantX is committed to eliminating the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

To learn more about this company, visit www.PlantX.com, www.PlantX.ca and www.Investor.PlantX.com and view the PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Predictive Oncology Inc. (NASDAQ: POAI) Receives ‘Buy’ Rating from Litchfield Hills Research in First Analyst Coverage Report

 

• Calling POAI undervalued, Litchfield initiates coverage of Predictive Oncology with Buy rating, $3 price target
• The drug industry is changing as tools and technology to tailor drugs emerge, regulatory bodies focus on patients’ experiences, perspectives, needs
• Litchfield report notes several POAI strengths under “Investment Thesis” section

A growing number of companies and health providers alike are paying attention to what the FDA is calling patient-focused drug development (“PFDD”), a systematic approach to help ensure that patients’ experiences, perspectives, needs and priorities are captured and meaningfully incorporated into drug development and evaluation. In that growing market, Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has been given a “Buy” rating by equity research firm Litchfield Hills Research LLC, which uses a three-tiered (buy-hold-sell) rating system (https://ibn.fm/lMp50).

“If you have ever had a medical condition that had to be treated with medication that had complex dosing requirements or complex directions for taking the medication, or side effects that made you stop, the drug industry is now paying attention,” noted Litchfield’s first analyst coverage report on Predictive Oncology. “Development of drugs to treat diseases was never tailored to any one individual because the tools to do that weren’t available, so development was generally not optimized for individual patient outcomes in terms of Active Pharmaceutical Ingredients (‘API’), side effects, getting the most out of the least amount of API (bioavailability), and medication regimen complexity and adherence.

“However, that is changing, especially as tools and technology to tailor drugs emerge, and the regulatory bodies, like the FDA, are focused on patient’s experiences, perspectives and needs,” the Litchfield report continued. “As experts in what it is like to live with their condition, patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation.”

The report notes several of POAI’s strengths under its “Investment Thesis” section, including that the company is “advancing state-of-the-art patient-centric drug development systems, which is the leading edge of current drug development, as the industry tries to reduce the time needed for commercial drug development.” Other strengths include that the company operates four subsidiaries, that its commercial business provides a stable revenue stream, and that the company has a strong balance sheet, having just completed a capital raise. In addition, the report notes that POAI has an “exceptional management team. The company has assembled an experienced management team for each of its pre-commercial subsidiaries to advance them towards commercialization.”

Calling POAI undervalued, Litchfield pronounced the following: “We are initiating coverage of Predictive Oncology Inc. with a Buy rating and a $3.00 price target. Predictive Oncology Inc. (NASDAQ: POAI) is a commercial stage biotech firm tackling cancer, assisting in vaccine development and solving medical waste issues.”

Litchfield Hills Research adheres to FINRA standards for quality and objectivity. The Litchfield Hills Research Department certifies its report is compliant with FINRA research rules 2241, 3110; that Litchfield is registered with FINRA; and that the report has been reviewed by a supervisory senior analyst. Litchfield’s price target, financial models, peer comparisons and investment thesis are developed without input from management of the company, and it performs its own due diligence. 

POAI is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.  

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Online Sales Products Platform Mohawk Group Holdings Inc. (NASDAQ: MWK) Sees Outlook Rise as Result of Pandemic Trends

 

• The COVID-19 pandemic is a year old, having devastated a number of markets since its discovery and spread were first reported in China
• While many industries have suffered worldwide during the year, the distancing requirements instituted in response to the pandemic have led buyers to turn to online retail outlets for many products
• Consumer products marketer Mohawk Group Holdings has been ideally situated to take advantage of the 44 percent growth in online commerce spending during 2020 and beyond
• Mohawk’s stock took an initial beating with the outbreak of the pandemic, but has since rebounded and rose more than 400 percent during the past three months alone
• The company’s holdings saw sales grow from $88.8 million to $144.2 million during the first nine months of 2020

Consumer products platform Mohawk Group Holdings (NASDAQ: MWK)  is riding a wave of optimism as an online retail marketer benefitting from the spike in remote access purchasing during the year-old COVID-19 pandemic.

Mohawk principally leverages its proprietary technology as a third-party seller on Amazon, and grew sales revenue from $88.8 million to $144.2 million during the first nine months of 2020 reported in its most recent quarterly filing (https://ibn.fm/TyCKQ).

An outside market opinion writer published this month in media outlet The Motley Fool noted that the company’s shares took a huge dive when the pandemic provoked strict commerce-limiting measures throughout the United States last year, but has also sharply rebounded.

“Yes, the stock is up over 400% in the past three months, but it is still early innings for this tech-enabled CPG (consumer packaged goods) conglomerate, so don’t fool yourself into thinking you’ve missed the boat with this business,” the opinion writer, Brett Schafer, states (https://ibn.fm/yV8Jc).

Schafer cited a Digital Commerce 360 report stating that e-commerce has experienced tremendous growth during the past year, with online shopping forming more than 20 percent of retail spending in the United States during 2020. The $861 billion spent online was a 44 percent increase over the previous year.

Amazon captured nearly a third of the online market share, with sales growth of 54 percent during the final quarter of the year. Mohawk’s position as a third-party Amazon seller allows it to ride the commerce giant’s coattails.

The company’s Artificial Intelligence Mohawk E-commerce Engine (“AIMEE”) helps it identify market opportunities then design, develop and launch products from its stable of 12 brands in categories including kitchenware and home appliances, environmental appliances, beauty products and consumer electronics.

Mohawk also sells its AIMEE software to other online sellers, granting the company revenue with high margins and a huge market opportunity. The company has offices in the United States, Canada, China and the Philippines and takes advantage of its global footprint to move its products around the clock.

The platform’s Fulfillment Engine helps to guide inventory location, cost optimization and use of third-party networks to cut shipping times.

When Mohawk announced the acquisition of online essential oils seller Healing Solutions, LLC in early February, the company reported it expects the acquisition to help boost its net revenues for 2021 to a range between $340 million to $370 million, with net income for the year estimated to reach between $1 million and $5 million primarily in response to quarterly interest expense, net and stock-based compensation expense.

Mohawk forecasts its adjusted EBITDA will be between $28 million and $32 million.

For more information, visit the company’s website at www.Mohawkgp.com.

NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at https://ibn.fm/MWK

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – HempFusion Wellness Inc. (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO) Common Shares Approved for DTC Full Service

 HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that the Depository Trust Company (“DTC”) has approved its common shares for DTC full-service eligibility. The approval is for the United States and means that the common shares can now be both traded and serviced through DTC’s electronic book-entry system. A subsidiary of the Depository Trust & Clearing Corp. (“DTCC”), DTC provides clearing and settlement services for the financial markets; the entity also settles securities transactions in the United States. By utilizing this electronic method of clearing securities, the receipt of stock and cash goes faster, ultimately quickening the entire settlement process for investors and brokers and allowing stock to be traded over a wider selection of brokerage firms. “By offering electronic settlement, DTC eligibility provides us with a larger platform to attract investors,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “From online trading platforms to banks to brokerage firms, the full spectrum of investors can now access our company resulting in more liquidity.”

To view the full press release, visit https://ibn.fm/veR7w

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at https://ibn.fm/CBDHF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Amesite Inc. (NASDAQ: AMST) Featured in “USA Today” Article Touting Demand for Online Learning Products

 Amesite (NASDAQ: AMST), an artificial intelligence (“AI”) software company providing the most advanced AI-powered online learning ecosystems for business, higher education and K-12, was founded to bring these types of organizations into the digital age. The company, which is committed to improving the way the world learns, works hard to ensure that education is accessible to everyone. Amesite was recently featured in “USA Today,” one of the media portfolio assets belonging to Gannett Co. Inc. (NYSE: GCI), a digitally focused media and marketing solutions company. The article highlights surging demand for customized and scalable online learning products offered in a single, easy-to-use format — this is the sweet spot for Amesite. The article also noted that Amesite’s current product portfolio is supplemented by a rich suite of services that support its partners as they implement new programs and improve existing ones. One of the services Amesite has recently added is Manage, a creative new functionality that enables schools and businesses to efficiently build and customize new courses or onboard existing ones at their own pace. The article points out that, even after the pandemic is over, online education will almost certainly continue to be an option, even as traditional in-class learning picks back up. “Online learning has the potential to transform all of education, and online tools are crucial for supporting all kinds of learning,” said Amesite CEO Ann Marie Sastry in the article. “Online offers flexibility, engagement and customization for students. Most importantly — it’s often the only practical way that professionals can upskill. So it’s absolutely essential that the best technology be deployed, to support growth for individuals and for enterprises.”

To view the full article, visit https://ibn.fm/NKjDa

About Amesite Inc.

Amesite is a high-tech, artificial intelligence software company offering a cloud-based platform and content creation services for business, university and K-12 learning and upskilling. Amesite-offered courses and programs are branded to its customers. For more information about the company, please visit www.Amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Releases Statement Clarifying Parllay Acquisition

 iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, has issued a clarification about its acquisition of Parllay, which had been previously announced. A marketing technology company with a global vision, Parllay has supported brands around the world, including Ford, Microsoft and Michelin, as they have implemented WeChat CRM and marketing automation designed to grow their businesses and increase the conversions. The company was established by a team of former Microsoft executives, top-level data scientists, and product and marketing experts and has grown into a trusted brand. Fortune 500 companies and top marketing agencies alike have used the company’s services. “Parllay is a leading personalized marketing platform with deep expertise in WeChat-based CRM, e-commerce and marketing SaaS solutions in China,” the company noted in the press release. “iClick anticipates utilizing Parllay’s rich expertise to further enhance iClick’s product offerings and accelerate sales of its Enterprise Solutions. The acquisition is estimated to close in the first half of 2021 and further details of the investment will be announced later.”

To view the full press release, visit https://ibn.fm/ZGmsS

About iClick Interactive Asia Group Limited

iClick Interactive is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China. Built on cutting-edge technologies, the company’s proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong, iClick was established in 2009 and is currently operating in 10 locations worldwide including Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html